Xiidra Solution/ Drops
Product Images NDC 0078-0911

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Xiidra (NDC 0078-0911). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Xiidra 01)

FDA Label Image

Figure 1 (Xiidra 02)

FDA Label Image

Figure 2 (Xiidra 03)

FDA Label Image

Figure A (Xiidra 04)

FDA Label Image

Figure B (Xiidra 05)

FDA Label Image

Figure C (Xiidra 06)

FDA Label Image

Figure D (Xiidra 07)

FDA Label Image

Figure E (Xiidra 08)

FDA Label Image

Figure F (Xiidra 09)

FDA Label Image

Figure G (Xiidra 10)

FDA Label Image

Figure H (Xiidra 11)

FDA Label Image

Principal Display Panel Ndc 0078-0911-12 Xiidra® (Xiidra 12)

Principal Display Panel Ndc 0078-0911-12 Xiidra® (Xiidra 12)
This appears to be a product information sheet for ophthalmic solution containing 5% Integrase for topical application. The product is contained in 0.2 ml containers and is manufactured by Novartis. The sheet also includes some unclear or nonsensical text, possibly due to errors.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.